Back to NVAX Stock Lookup

Novavax (NVAX) – Globe Newswire

Mar 8, 2021 06:00 PM Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat
Mar 1, 2021 04:02 PM Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Feb 26, 2021 08:22 AM Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Feb 26, 2021 08:22 AM Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Feb 22, 2021 07:00 AM Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Feb 22, 2021 07:00 AM Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Feb 18, 2021 04:02 PM Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Feb 18, 2021 04:02 PM Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Feb 16, 2021 08:00 AM Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021
Feb 15, 2021 08:04 PM Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Feb 15, 2021 08:04 PM Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea
Feb 4, 2021 04:05 PM Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Feb 4, 2021 04:05 PM Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Feb 3, 2021 09:14 PM Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Feb 2, 2021 12:31 PM Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
Feb 1, 2021 07:32 PM Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
Jan 28, 2021 04:05 PM Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Jan 28, 2021 04:05 PM Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Jan 22, 2021 05:22 PM Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Jan 22, 2021 05:22 PM Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Jan 22, 2021 04:49 PM Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
Jan 15, 2021 08:00 AM Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Jan 15, 2021 08:00 AM Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Jan 7, 2021 06:14 PM Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine
Jan 7, 2021 06:14 PM Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine
Jan 6, 2021 09:00 AM Novavax to Participate in Upcoming Conferences
Dec 28, 2020 09:20 AM Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
Dec 28, 2020 09:20 AM Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
Dec 21, 2020 05:42 PM Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer
Dec 21, 2020 05:42 PM Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer
Dec 16, 2020 07:07 PM Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Dec 16, 2020 07:07 PM Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Dec 9, 2020 08:02 AM Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
Dec 9, 2020 08:02 AM Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
Nov 30, 2020 06:30 AM Novavax Announces COVID-19 Vaccine Clinical Development Progress
Nov 30, 2020 06:30 AM Novavax Announces COVID-19 Vaccine Clinical Development Progress
Nov 25, 2020 04:15 PM Novavax to Participate in Upcoming Conferences
Nov 25, 2020 04:15 PM Novavax to Participate in Upcoming Conferences
Nov 10, 2020 09:18 AM Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
Nov 10, 2020 09:18 AM Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
Nov 9, 2020 04:05 PM Novavax Reports Third Quarter 2020 Financial and Operational Results
Nov 9, 2020 04:05 PM Novavax Reports Third Quarter 2020 Financial and Operational Results
Nov 9, 2020 04:02 PM Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
Nov 9, 2020 04:02 PM Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
Nov 9, 2020 08:30 AM Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Nov 9, 2020 08:30 AM Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Nov 4, 2020 09:52 AM Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
Nov 4, 2020 09:51 AM Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
Nov 3, 2020 05:32 PM Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
Nov 3, 2020 05:32 PM Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors

Back to NVAX Stock Lookup